IMPG1

interphotoreceptor matrix proteoglycan 1

Basic information

Region (hg38): 6:75921114-76072678

Previous symbols: [ "SPACR" ]

Links

ENSG00000112706NCBI:3617OMIM:602870HGNC:6055Uniprot:Q17R60AlphaFoldGenCCjaxSfariGnomADPubmedClinVar

Phenotypes

GenCC

Source: genCC

  • retinitis pigmentosa (Moderate), mode of inheritance: AR
  • retinitis pigmentosa (Moderate), mode of inheritance: AD
  • vitelliform macular dystrophy 4 (Moderate), mode of inheritance: AD
  • adult-onset foveomacular vitelliform dystrophy (Supportive), mode of inheritance: AD
  • vitelliform macular dystrophy 4 (Strong), mode of inheritance: AD
  • inherited retinal dystrophy (Definitive), mode of inheritance: AD
  • vitelliform macular dystrophy 4 (Definitive), mode of inheritance: AR

Clinical Genomic Database

Source: CGD

ConditionInheritanceIntervention CategoriesIntervention/Rationale Manifestation CategoriesReferences
Macular dystrophy, vitelliform, 4; Retinitis pigmentosa 91; Retinitis pigmentosa 56AD/ARGeneralGenetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testingOphthalmologic23993198; 25085631; 30589393; 32817297

ClinVar

This is a list of variants' phenotypes submitted to ClinVar and linked to the IMPG1 gene.

  • not provided (37 variants)
  • Vitelliform macular dystrophy 4 (2 variants)
  • IMPG1-related disorder (1 variants)
  • Retinal dystrophy (1 variants)
  • Vitelliform macular dystrophy 2 (1 variants)

Variants pathogenicity by type

Statistics on ClinVar variants can assist in determining whether a specific variant type in the IMPG1 gene is commonly pathogenic or not.

In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.

Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.

Variant type Pathogenic Likely pathogenic VUS Likely benign Benign Sum
synonymous
5
clinvar
109
clinvar
6
clinvar
120
missense
1
clinvar
319
clinvar
6
clinvar
15
clinvar
341
nonsense
13
clinvar
4
clinvar
4
clinvar
21
start loss
2
clinvar
2
frameshift
22
clinvar
1
clinvar
2
clinvar
25
inframe indel
5
clinvar
5
splice donor/acceptor (+/-2bp)
3
clinvar
11
clinvar
3
clinvar
17
splice region
1
19
24
2
46
non coding
1
clinvar
53
clinvar
2
clinvar
56
Total 38 17 341 168 23

Highest pathogenic variant AF is 0.0000460

Variants in IMPG1

This is a list of pathogenic ClinVar variants found in the IMPG1 region.

You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.

Position Type Phenotype Significance ClinVar
6-75922092-A-G Retinal dystrophy Conflicting classifications of pathogenicity (Oct 22, 2023)866722
6-75922100-C-T Uncertain significance (Mar 10, 2022)1483378
6-75922104-A-G Likely benign (Jun 05, 2024)3616899
6-75922106-C-T Retinal dystrophy Benign (Jan 30, 2024)1166320
6-75922107-T-C Likely benign (Nov 18, 2024)1508964
6-75922119-T-A Uncertain significance (Dec 19, 2023)2756077
6-75922121-C-A Vitelliform macular dystrophy 4 Uncertain significance (Jan 11, 2023)1810752
6-75922133-C-T not specified Conflicting classifications of pathogenicity (Jan 25, 2024)946530
6-75922139-G-A Likely benign (Apr 19, 2023)2847509
6-75922144-TC-T Uncertain significance (Sep 15, 2022)1010628
6-75922158-A-G Likely benign (Sep 04, 2020)1131043
6-75922159-C-T not specified Uncertain significance (Nov 18, 2024)1006453
6-75922166-C-T Uncertain significance (Oct 22, 2023)2001168
6-75922168-TGAAAGA-T Uncertain significance (Apr 02, 2022)1911491
6-75922180-A-C Likely benign (Jun 04, 2022)1900890
6-75923626-G-T Likely benign (Dec 11, 2022)2820157
6-75923627-A-AT Benign (Jan 15, 2024)1169591
6-75923634-C-T Uncertain significance (Jul 02, 2022)1968721
6-75923645-G-A Uncertain significance (Oct 04, 2022)1484226
6-75923647-T-TGATTTTGGAACTTTTTTTTTTTTTTTTTTTTTTTTTNNNNNNNNNNCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCGCCCCCCCCCCCCGGGAGCGGGAGAGGGAGAGG Uncertain significance (May 24, 2023)2709426
6-75923656-A-G Uncertain significance (Nov 03, 2023)838276
6-75923657-A-C not specified Uncertain significance (Mar 01, 2023)2065474
6-75923658-C-A Uncertain significance (Jun 05, 2024)1058155
6-75923667-A-G Likely benign (Feb 08, 2022)1096537
6-75923668-C-T Retinal dystrophy Benign (Jan 31, 2024)1164207

GnomAD

Source: gnomAD

GeneTypeBio TypeTranscript Coding Exons Length
IMPG1protein_codingprotein_codingENST00000369950 17151564
pLI Probability
LOF Intolerant
pRec Probability
LOF Recessive
Individuals with
no LOFs
Individuals with
Homozygous LOFs
Individuals with
Heterozygous LOFs
Defined p
1.37e-290.00003391256700781257480.000310
Z-Score Observed Expected Observed/Expected Mutation Rate Total Possible in Transcript
Missense-0.9374764221.130.00002115242
Missense in Polyphen10697.6981.0851337
Synonymous0.08781541550.9910.000008631509
Loss of Function-0.2954341.01.050.00000225471

LoF frequencies by population

EthnicitySum of pLOFs p
African & African-American0.0007540.000631
Ashkenazi Jewish0.00009970.0000992
East Asian0.0004350.000435
Finnish0.000.00
European (Non-Finnish)0.0003560.000352
Middle Eastern0.0004350.000435
South Asian0.0004390.000425
Other0.000.00

dbNSFP

Source: dbNSFP

Function
FUNCTION: May interact with hyaluronan which may serve to form a basic macromolecular scaffold comprising the insoluble interphotoreceptor matrix. {ECO:0000269|PubMed:9813076}.;
Disease
DISEASE: Macular dystrophy, vitelliform, 4 (VMD4) [MIM:616151]: A form of macular dystrophy, a retinal disease in which various forms of deposits, pigmentary changes, and atrophic lesions are observed in the macula lutea. Vitelliform macular dystrophies are characterized by yellow, lipofuscin-containing deposits, usually localized at the center of the macula. VMD4 features include late- onset moderate visual impairment, small satellite drusen-like lesions in the foveal area, and preservation of retinal pigment epithelium reflectivity. {ECO:0000269|PubMed:23993198}. Note=The disease is caused by mutations affecting the gene represented in this entry.;

Recessive Scores

pRec
0.0918

Intolerance Scores

loftool
0.964
rvis_EVS
0.69
rvis_percentile_EVS
85.29

Haploinsufficiency Scores

pHI
0.269
hipred
N
hipred_score
0.112
ghis

Essentials

essential_gene_CRISPR
N
essential_gene_CRISPR2
N
essential_gene_gene_trap
N
gene_indispensability_pred
N
gene_indispensability_score
0.0100

Gene Damage Prediction

AllRecessiveDominant
MendelianMediumMediumMedium
Primary ImmunodeficiencyMediumMediumMedium
CancerMediumMediumMedium

Mouse Genome Informatics

Gene name
Impg1
Phenotype

Gene ontology

Biological process
visual perception
Cellular component
extracellular matrix
Molecular function
extracellular matrix structural constituent